{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-091109","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2025-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.648888+00:00","generated_at":"2026-05-17T05:49:21.616262+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cadrenal Therapeutics elects Steven Zelenkofske as director; ratifies auditor","bullets":["At 2025 annual meeting, stockholders elected Steven Zelenkofske as Class III director with 669,494 votes for, 15,099 withheld.","Ratification of WithumSmith+Brown as FY2025 auditor passed with 1,207,152 votes for, 64,913 against, 12,681 abstain.","Broker non-votes of 600,153 on director election; none on auditor ratification (routine matter).","Meeting held September 24, 2025; quorum of 1,284,746 shares out of 2,046,854 outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-091109","json":"https://secwatch.observer/filing/0001213900-25-091109.json","markdown":"https://secwatch.observer/filing/0001213900-25-091109.md","text":"https://secwatch.observer/filing/0001213900-25-091109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025091109/0001213900-25-091109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025091109/ea0258629-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:49:21.616262+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}